Position in NTRA
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$541,271
+$89,494 QoQ
Shares Held
1,994
-11.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#518
of 844 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Net Worth Advisory Group holds $3,377,385 across 7 Diagnostics & Research names. NTRA ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
4,833 | $1,024,354 | |
| 2 | DHR |
Danaher Corp /De/
|
3,382 | $644,203 | |
| 3 | NTRA |
Natera, Inc.
This page
|
1,994 | $541,271 | |
| 4 | ICLR |
Icon PLC
|
2,389 | $414,993 | |
| 5 | RVTY |
Revvity, Inc.
|
2,707 | $301,180 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
2,733 | $234,491 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
412 | $216,893 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,271 | 1,994 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $451,777 | 2,259 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $609,379 | 2,660 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $491,602 | 3,054 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $574,902 | 3,403 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $504,833 | 3,570 | Shares | Sole | 2025-04-15 | |
| No filing history on record for this holder in this stock. | ||||||